Stroke Trial, Recruiting NCT06390423 Sponsor: CentraCare Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06390423
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People between 30 and 90 years of age
  • People who have been diagnosed with vasodilatory shock, which is dangerously low blood pressure caused by blood vessels widening, with no other clear cause identified
  • People who have been diagnosed with a serious lung condition called Acute Respiratory Distress Syndrome (ARDS), where oxygen levels in the blood are very low and significant breathing support is needed
  • People who are on a mechanical ventilator (a machine that breathes for them) and are either in a deep medically induced sleep or have been given medication to stop muscle movement

Who may not be able to join:

  • People who have an irregular heartbeat, including a condition called atrial fibrillation
  • People who have a chest drain tube in place, or who have, or are at risk of, dangerously raised pressure inside the abdomen
  • People who have structural problems with their heart, including high blood pressure in the lungs (a condition called pulmonary hypertension) or heart failure
  • People who are receiving advanced life support machines such as ECMO (a machine that does the work of the heart and lungs), CRRT (a kidney filtering machine), or mechanical heart support devices
  • People who have chronic obstructive pulmonary disease (COPD) with significantly reduced lung function measured before this illness (confirm with trial site)
  • People who have severe narrowing or hardening of the arteries throughout the body

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ramakanth Pata, MD FCCP, Centracare health System

Phone: 320-240-2207

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
CentraCare
Registry
ClinicalTrials.gov
Start date
1 July 2023
Est. completion
1 June 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Vasopressor dose in Nor-epinephrine equivalents (NE) measured as mcg/kg/min

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov